Medicine Platform
搜索
Product Catagories
首页 > Pharmaceutical Materials > Tofacitinib Citrate
Tofacitinib Citrate
单价 面议对比
询价 暂无
发货
过期 长期有效
更新 2025-08-14 11:10
 
详细信息

Grade: Pharmaceutical Grade

Factory Location: Guangan city ,Sichuan province, China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Packaging Information: 25KG/Drum

Delivery Lead Time: 30 days

Sample Provided: yes

Payment Terms: T/T

Tofacitinib Citrate an inhibitor of Janus kinases (JAKs), is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).